Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18669987.
- Also identified by DOI 10.1192/bjp.bp.108.051268.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The National Strategic Framework for Renal Services introduced the routine reporting of estimated glomerular filtration rates (eGFR) on serum urea and electrolyte tests. Estimated glomerular filtration rates might reduce renal failure induced by lithium and cardiovascular mortality but there are many false positives. We propose how eGFR might be used in lithium monitoring.
Medical subject headings
- Glomerular Filtration Rate
- Kidney Failure, Chronic
- Kidney Function Tests
- Lithium Compounds